The clinical features of Prader-Willi Syndrome (PWS) in the neonate are marked by hypotonia, absence of crying, and feeding difficulties, but the clinical nature of PWS in utero remains unclear. We report a case of PWS with fetal immobility and distal arthrogryposis in a girl admitted the first day of life to the neonatal intensive care unit for severe hypotonia and respiratory distress.
INTRODUCTION
Prader-Willi syndrome (PWS) is a neurobehavioral disorder first described in 1956. 1 It is the most frequent syndrome with chromosomal microdeletions, and the most common type of obesity of genetic origin. 2 In addition, it is one of the two first human diseases acknowledged as being determined by the genomic imprinting mechanism. 3 During the past few years, the genetic bases of PWS has been extensively investigated; still the clinical diagnosis of this disorder is complex, considering that some characteristics change according to the age and can be present in other syndromes as well. Particularly in neonate, the clinical features of PWS are marked by hypotonia, absence of crying, and feeding difficulties, 4 but the clinical nature of PWS in utero remains unclear. We report a case of PWS with fetal immobility and distal arthrogryposis in a girl admitted the first day of life to the neonatal intensive care unit for severe hypotonia and respiratory distress.
Case Report
We report the case of a female infant born to a gravida 2, para 2, 36-year-old woman. The mother's pregnancy had been marked by hydramnios involving amnioreduction at 31 weeks of gestation associated with fetal immobility and lack of deglutition. In the antenatal period, a standard chromosome banding study, encephalic nuclear magnetic resonance (NMR), cytomegalovirus serologies, testing for Steinert's disease and the Kleihauer test remained normal. Deglutition movements appeared in the last month of pregnancy. Birth was initiated at 38 WG because of a decrease in fetal heart rate. Birth weight, height and cranial perimeter were normal. Apgar scores were 3 and 5 at 1 and 5 min, respectively. Severe hypotonia with distal arthrogryposis were immediately recognized. A total absence of gesticulation in the first days of life was associated with oxygen dependence. Hypotonia was nonprogressive but persistent until discharge. In addition, we observed a lack of deglutition in the first weeks of life with poor sucking and alimentation autonomy at 1 month of life. Another sign was distal arthrogryposis with bilateral articular stiffness of hands and feet. Postnatal transfontanelle ultrasound, NMR and electroencephalogram were normal. The electromyogram showed hyporeflexivity of central origin. Biological level of creatinine kinase (CK) remained normal. Standard chromosome banding studies were normal (46, XX. Isch 15q11.2 (SNRPNx 2)). In molecular biology analysis, methylation studies revealed an absence of the paternally donated imprinting center indicative of PWS. This diagnosis was made at 15 days of life; later, parental study showed maternal uniparental disomy (inheritance of two maternal chromosome 15).
DISCUSSION
Establishing the diagnosis of PWS early is very important because it gives the parents the opportunity of providing adequate diets and stimulating appropriate eating and exercise habits. This is to reduce problems related to obesity: including; diabetes, hypertension and respiratory issues that are the main causes of death among these patients during adolescence. In addition, early diagnosis prompts the parents to seek professional help. PWS results from the absence of paternal genes that are usually active in chromosomal segment 15 q11q13; the maternal inherited alleles are usually inactive, due to the genomic imprinting mechanisms. Of the PWS cases, 75% present paternal deletion of segment 15q11q13, 20 to 25% of the PWS present maternal uniparental disomy, and approximately 5% of the PWS present translocation or other structural chromosomal anomaly involving chromosome 15, around 1% of the patients do not present deletion or uniparental disomy but instead present a microdeletion in the imprinting controller center located in segment 15q11q13.
The most efficient method to diagnose PWS is a molecular test that determines the progenitor-specific methylation pattern in the PWS/AS region using Southern blot and hybridization with probes sensitive to methylation of the SNRPN and PW 71 loci. A normal methylation pattern eliminates the possibility of PWS with 95% certainty. The prenatal diagnosis through the study of the methylation pattern is possible.
Diagnosis of PWS is based on clinical findings that change with age. 5 Antenatal symptoms such as decreased fetal movement remain minor criteria, whereas hydramnios, abnormal fetal heart rhythm, malpresentation, deglutition disorders and arthrogryposis can alert clinicians and may offer clues for prenatal diagnosis of PWS. 6 A possible diagnosis of PWS should be considered for all neonates with undiagnosed central hypotonia. Early diagnosis of PWS is of major importance for the family and could improve the care of these complex patients. 7 We report the first association of PWS with distal arthrogryposis. We suggest genetic testing for this disease be requested more frequently in antenatal period. This may help the establishment of an earlier diagnosis and decreasing the need for more invasive diagnostic resources.
